Taken together, our data showed that HMGB1 in SLE bone marrow inflammatory microenvironment could promote the senescence of MSCs via TLR4/NF-κB signaling pathway, and inhibiting HMGB1 by EP could improve lupus nephritis and reverse the senescence signs. Here, NFKB1 is linked to systemic lupus erythematosus.